Performing Third-Party IP Review on a Drug for Different Markets: A Case Study
Entities owning patent portfolios are often involved in licensing, acquisition, and partnership activities with investors, R&D groups, or start-up accelerators. Such business transactions require thorough due diligence and third-party expert’s opinion to determine the profitability scope for investing/partnering party or licensee. Portfolio owners sometimes take the first step in the IP review for effective negotiations with the potential investors/licensees and to forecast extension to newer markets. However, many businesses reach out to an expert third party for professional IP review and recommendations.
Comments
Post a Comment